Zymosan activated plasma infusion in sheep: Effects of ethanol administration Academic Article uri icon


MeSH Major

  • Certification
  • General Surgery
  • Medical Oncology
  • Neoplasms
  • Physicians


  • Zymosan activated plasma infusion induces pulmonary sequestration of neutrophils and the release of TXA2 into the pulmonary vascular bed causing profound and transient pulmonary hypertension. Since ethanol (ETOH) inhibits several inflammatory functions of neutrophils, including adherence and aggregation, we examined the ability of anesthetic doses of ETOH to alter the hemodynamic and cellular response to the infusion of zymosan activated plasma (ZAP) in vivo. Twenty five ml of autologous ZAP was intravenously infused into five control and seven (ETOH-treated sheep during mechanical ventillation. In control sheep the mean pulmonary artery pressure (PAP) transiently increased from 14.7±1.4 mm Hg (mean±SEM) to a pead of 38+8 mm Hg by three minutes after beginning the infusion of ZAP. Blood leukocyte concentration transiently decreased 19% below the baseline value due to pulmonary sequestration of polymorphonuclear leukocytes (PMN). Plasma TXB2 levels measured by radioimmunoassay (RIA) increased from 0.2 to 5.4 ng/ml six minutes after the initiation of ZAP infusion. In five sheep, intravenous infusion of 200 ml of 96% ETOH yielded very high plasma concentrations (882±101 mg%) and completely inhibited both the rise of PAP and the increase of plasma TXB2 levels after ZAP infusion. However, blood leukocytes transiently decreased 58% below the baseline value. Lower plasma levels of ETOH (200 and 400 mg%) did not prevent either the increase of PAP or the elevation of plasma TXB2 after ZAP infusion. © 1984.

publication date

  • January 1984



  • Academic Article


Digital Object Identifier (DOI)

  • 10.1016/0090-6980(84)90178-3

Additional Document Info

start page

  • 695

end page

  • 709


  • 28


  • 5